Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
CVS
$97.16
+2.28%
CVS · CVS HEALTH Corp
$97.16
+2.17 (+2.28%)
At close · Aug 14
Market Cap
$124.26B
Shares
1.28B
All earnings calls
Earnings call · FY2026 Q2
Q2 2026 Earnings Conference Call
Q2 2026 Earnings Conference Call
Forward guidance
4 guided metrics
Management's latest ranges and targets are included below.
Research coverage
3 live sources
Switch sources without leaving this page or losing your listening position.
Revenue
$106.10B
+7.3% YoY
Diluted EPS
$2.31
+188.8% YoY
Net income
$2.98B
+191.8% YoY
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Aug 5, 2026.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
GAAP diluted EPS
full-year 2026
|
$6.84 – $7.04 | GAAP | |
|
Adjusted EPS
full-year 2026
|
$7.90 – $8.10 | Non-GAAP | |
|
Cash flow from operations
full-year 2026
|
at least $11.5B | — | |
|
Total revenues
full-year 2026
|
at least $414B | — |
Quarter detail
How the reported period landed and where the business moved.
Company presentation
Slides
12 pages · use arrow keys or swipe to navigate
SEC filing · Item 2.02
8-K earnings release
Filed Aug 5, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 5, 2026 · complete as-filed document